No action required for AZN common stock holders. This filing relates solely to the delisting of a matured bond guarantee and has no read-through for AstraZeneca's equity, credit profile, or operations. Monitor for any future cross-filings if the company restructures its debt guarantees, but this event is routine.
AZN drugs
AZN drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · May 28 $185.34entry
- T+1 · 6mo ago +0.08%α −0.16% · $185.49
- T+5 · 6mo ago −1.94%α −2.25% · $181.75
- T+20 · 5mo ago +0.19%α +2.88% · $185.68
- T+60 · 3mo ago −10.53%α −12.01% · $165.82
Price Chart
How similar events traded
Executive Summary
The NYSE filed a Form 25-NSE to delist a guarantor of AstraZeneca's 1.200% Notes due 2026, following the notes' redemption at maturity on May 28, 2026. This is a routine administrative delisting of a matured debt security, not the company's common stock, and has no financial or operational impact on AstraZeneca PLC.
Key Facts
- Form 25-NSE filed by NYSE on May 28, 2026 to delist and deregister the guarantor of AstraZeneca's 1.200% Notes due 2026
- The notes were redeemed or paid at maturity on May 28, 2026, per 17 CFR 240.12d2-2(a)(2)
- Delisting effective at the opening of business on June 8, 2026
- The security was suspended from trading on May 28, 2026
- This affects only the specific debt security (guarantor of 1.200% Notes due 2026), not AZN common stock
- AstraZeneca's common stock (AZN) remains listed on the NYSE
Financial Impact
No material financial impact, relates to a matured debt security, not the company's equity
Risk Factors
- None, this is a standard post-maturity administrative filing with zero impact on AZN equity
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 25-NSE Filing (Primary) | 0000876661-26-000484 |
| Document: 0000876661-26-000484-index.html | 0000876661-26-000484 |
| Document: 0000876661-26-000484.txt | 0000876661-26-000484 |
Track record
77 reports on AZN
19 of 38 bullish or bearish reports moved the stock their way by T+5. Best: +20.72% at T+60 after the Aug 17, 2026 report. 29 of 38 went positive at some point.
Filters
- Nov 16, 2026today 6-K Bullish 6/10 Entry price pending
- Nov 16, 2026today 6-K Bullish 6/10 Entry $185.55 Now $184.02 −0.82% settles Nov 23
- Nov 16, 2026today 6-K Bullish 6/10 Entry $185.31 Now $184.02 −0.70% settles Nov 23
- Nov 16, 2026today 6-K Bullish 5/10 Entry $185.09 Now $184.02 −0.58% settles Nov 23
- Nov 4, 202612d ago Institutional Cluster Mixed 3/10 Entry $186.85 to $184.38 Now $184.02 −1.51% ▼ −1.32% −4.61% vs SPY
- Nov 2, 202614d ago 6-K Neutral 1/10 Entry $186.58 to $189.39 Now $184.02 −1.37% ▲ +1.51% +1.43% vs SPY
- Nov 2, 202614d ago 6-K Neutral 1/10 Entry $186.58 to $189.39 Now $184.02 −1.37% ▲ +1.51% +1.43% vs SPY
- Oct 30, 202617d ago 6-K Neutral 5/10 Entry $186.65 to $186.43 Now $184.02 −1.41% ▼ −0.12% +2.59% vs SPY
- Oct 27, 202620d ago 6-K Bullish 5/10 Entry $170.08 to $183.88 Now $184.02 +8.20% ▲ +8.11% +10.10% vs SPY
- Oct 22, 202625d ago 6-K Bullish 6/10 Entry $172.57 to $173.46 Now $184.02 +6.63% ▲ +0.51% −0.19% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers